MedTrace Logo

Glycemic Response to Two Doses of Low Sugar Apple Juice

NCT04747639 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2021-08-04

No results posted yet for this study

Summary

Single center, double-blind, randomized controlled cross-over trial with four treatments and four time points.

The study has three primary objectives. The first primary objective is to confirm the reduction of postprandial glycemic and insulinemic response after consumption of 500 ml glucose-free apple juice compared to 500 ml untreated apple juice as could be shown in a previous study

Conditions

Interventions

OTHER

500 ml glucose-depleted apple juice

OTHER

500 ml conventional apple juice

OTHER

250 ml glucose-depleted apple juice

OTHER

250 ml conventional apple juice

Sponsors & Collaborators

  • Nofima

    collaborator OTHER

  • Clinical Research Center Kiel GmbH

    lead OTHER

Principal Investigators

  • Christiane Laue, Dr. (MD) · CRC Clinical Research Center Kiel

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-28
Primary Completion
2016-05-09
Completion
2021-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04747639 on ClinicalTrials.gov